Weyland Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$304K Sell
4,153
-420
-9% -$29.9K 0.32% 8
2016
Q1
$323K Buy
4,573
+1,300
+40% +$86.5K 0.34% 8
2015
Q4
$218K Sell
3,273
-1,644
-33% -$109K 0.2% 8
2015
Q3
$312K Hold
4,917
0.29% 7
2015
Q2
$322K Sell
4,917
-4,176
-46% -$283K 0.28% 7
2015
Q1
$631K Buy
9,093
+1,600
+21% +$111K 0.54% 7
2014
Q4
$518K Hold
7,493
0.46% 7
2014
Q3
$489K Sell
7,493
-615
-8% -$40.6K 0.44% 8
2014
Q2
$553K Sell
8,108
-300
-4% -$20.1K 0.49% 7
2014
Q1
$545K Buy
8,408
+1,600
+24% +$101K 0.5% 7
2013
Q4
$444K Hold
6,808
0.43% 8
2013
Q3
$404K Hold
6,808
0.42% 8
2013
Q2
$390K Buy
+6,808
New +$404K 0.45% 8

Other funds holding CL

Weyland Capital Management's CL Position: Q2 2016 in Review

Weyland Capital Management reduced its Colgate-Palmolive (CL) stake by 9.2% in Q2 2016, selling an estimated $29.9K and leaving 4,153 shares worth $304K. The position accounts for 0.32% of the portfolio, ranked #8.

Weyland Capital Management first reported a position in CL in Q2 2013 and has held it in 13 quarters since. The position peaked at $631K in Q1 2015. 1,284 funds tracked by Wall St. Rank hold CL as of Q2 2016.

  • Weyland Capital Management held 4,153 shares of Colgate-Palmolive worth $304K as of Q2 2016.
  • Weyland Capital Management sold 420 Colgate-Palmolive shares in Q2 2016, an estimated $29.9K.
  • Colgate-Palmolive made up 0.32% of Weyland Capital Management's portfolio in Q2 2016, its #8 holding.
  • Weyland Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 13 quarters since.
  • Weyland Capital Management's Colgate-Palmolive position peaked at $631K in Q1 2015.
  • 1,284 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2016.

Based on Weyland Capital Management's 13F filing for Q2 2016, filed 28 Jul 2016.